We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 105 results
  1. The feasibility of [18F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study

    Rationale

    Evaluation of the feasibility of [ 18 F]EF5-PET/CT scan in identifying hypoxic lesions in ovarian tumors in prospective clinical setting.

    ...
    Maren Laasik, Johanna Hynninen, ... Sakari Hietanen in EJNMMI Research
    Article Open access 10 September 2020
  2. Detection of metabolic adaptation in a triple-negative breast cancer animal model with [18F]choline-PET imaging as a surrogate for drug resistance

    Purpose

    Test the feasibility of an image-based method to identify taxane resistance in mouse bearing triple-negative breast cancer (TNBC) tumor...

    Andres A. Kohan, Mathieu Lupien, ... Patrick Veit-Haibach in European Journal of Nuclear Medicine and Molecular Imaging
    Article 14 December 2023
  3. Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers

    Purpose

    High-grade gliomas are aggressive primitive brain tumors presenting aberrant vasculature, regional necrosis, and areas of hypoxia. Tumor...

    Natale Quartuccio, Riccardo Laudicella, ... Maria Picchio in Clinical and Translational Imaging
    Article 06 February 2020
  4. Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer

    Purpose

    Hypoxia contributes to radiotherapy resistance and more aggressive behaviour of several types of cancer. This study was designed to evaluate...

    Antti Silvoniemi, Sami Suilamo, ... Heikki Minn in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 26 October 2017
  5. Closing the gap between 19F and 18F chemistry

    Positron emission tomography (PET) has become an invaluable tool for drug discovery and diagnosis. The positron-emitting radionuclide fluorine-18 is...

    Javier Ajenjo, Gianluca Destro, ... Véronique Gouverneur in EJNMMI Radiopharmacy and Chemistry
    Article Open access 25 September 2021
  6. Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patients

    Background

    Tumour hypoxia promotes an aggressive tumour phenotype and enhances resistance to anticancer treatments. Following the recent observation...

    Pauline Bourigault, Michael Skwarski, ... Daniel R. McGowan in EJNMMI Research
    Article Open access 29 December 2021
  7. Highlight selection of radiochemistry and radiopharmacy developments by editorial board

    Background

    The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in...

    Jun Toyohara, Mohammed Al-Qahtani, ... Emerson Bernardes in EJNMMI Radiopharmacy and Chemistry
    Article Open access 01 October 2022
  8. Synthesis of a 2-nitroimidazole derivative N-(4-[18F]fluorobenzyl)-2-(2-nitro-1H-imidazol-1-yl)-acetamide ([18 F]FBNA) as PET radiotracer for imaging tumor hypoxia

    Background

    Tissue hypoxia is a pathological condition characterized by reducing oxygen supply. Hypoxia is a hallmark of tumor environment and is...

    Arian Pérez Nario, Jenilee Woodfield, ... Emerson Soares Bernardes in EJNMMI Radiopharmacy and Chemistry
    Article Open access 13 June 2022
  9. Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors

    Purpose

    Glycolysis is increased by hypoxia, suggesting a possible correlation between the accumulation of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) in...

    Sadek A. Nehmeh, Mohamed B. Moussa, ... Heiko Schöder in EJNMMI Research
    Article Open access 14 April 2021
  10. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine

    Targeted radionuclide theranostics is becoming more and more prominent in clinical oncology. Currently, most nuclear medicine compounds researched...

    Circe D. van der Heide, Simone U. Dalm in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 05 July 2022
  11. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

    Having a hypoxic microenvironment is a common and salient feature of most solid tumors. Hypoxia has a profound effect on the biological behavior and...

    Zhou Chen, Fangfang Han, ... Wence Zhou in Signal Transduction and Targeted Therapy
    Article Open access 17 February 2023
  12. Therapeutic targeting of the hypoxic tumour microenvironment

    Hypoxia is prevalent in human tumours and contributes to microenvironments that shape cancer evolution and adversely affect therapeutic outcomes....

    Dean C. Singleton, Andrew Macann, William R. Wilson in Nature Reviews Clinical Oncology
    Article 29 July 2021
  13. Positron Emission Tomography and Molecular Imaging of Head and Neck Malignancies

    Purpose of Review

    Metabolic reprogramming and avid fluorodeoxyglucose (FDG) uptake in locally advanced head and neck squamous cell carcinomas and...

    Farshad Moradi in Current Radiology Reports
    Article 11 September 2020
  14. Targeting hypoxic tumor microenvironment in pancreatic cancer

    Attributable to its late diagnosis, early metastasis, and poor prognosis, pancreatic cancer remains one of the most lethal diseases worldwide. Unlike...

    **xin Tao, Gang Yang, ... Yupei Zhao in Journal of Hematology & Oncology
    Article Open access 13 January 2021
  15. Evaluation of repeated [18F]EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas

    Background

    Tumor hypoxia is linked to invasion and metastasis but whether this associates with tumor growth rate is not well understood. We aimed to...

    Antti Silvoniemi, Jonna Silén, ... Tove J Grönroos in EJNMMI Research
    Article Open access 16 December 2014
  16. Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity

    Background

    Autophagy is a survival mechanism that allows recycling of cellular breakdown products, particularly in stressed cells. Here we evaluate...

    Qian Tan, A. M. Joshua, ... Ian F. Tannock in Cancer Chemotherapy and Pharmacology
    Article 04 April 2017
  17. Impact of hypoxia in head and neck cancer radiotherapy

    Background

    Radiotherapy plays an important role in the treatment of pharyngo-laryngeal and oral cavity head and neck squamous cell carcinoma (HNSCC)...

    Vincent Grégoire, Jesper Eriksen in Clinical and Translational Imaging
    Article 24 October 2017
  18. Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy

    Purpose

    In order to improve the treatment of squamous cell carcinoma of the head and neck, precise information on the treated tumour’s biology is...

    Gaber Komar, Kaisa Lehtiö, ... Heikki Minn in European Journal of Nuclear Medicine and Molecular Imaging
    Article 05 June 2014
Did you find what you were looking for? Share feedback.